Rank | Gene Set | Z-score |
---|---|---|
1 | negative regulation of erythrocyte differentiation (GO:0045647) | 5.97087598 |
2 | L-phenylalanine metabolic process (GO:0006558) | 4.72960293 |
3 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 4.72960293 |
4 | lysine catabolic process (GO:0006554) | 4.55258319 |
5 | lysine metabolic process (GO:0006553) | 4.55258319 |
6 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 4.45493036 |
7 | serine family amino acid catabolic process (GO:0009071) | 4.14612044 |
8 | glycine metabolic process (GO:0006544) | 4.14271242 |
9 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 4.12260258 |
10 | L-phenylalanine catabolic process (GO:0006559) | 4.12260258 |
11 | cysteine metabolic process (GO:0006534) | 4.07075714 |
12 | heme biosynthetic process (GO:0006783) | 4.00787847 |
13 | sulfur amino acid catabolic process (GO:0000098) | 3.94628637 |
14 | amino-acid betaine metabolic process (GO:0006577) | 3.89703931 |
15 | porphyrin-containing compound biosynthetic process (GO:0006779) | 3.87687093 |
16 | 3-UTR-mediated mRNA stabilization (GO:0070935) | 3.86755755 |
17 | GDP-mannose metabolic process (GO:0019673) | 3.82656282 |
18 | glyoxylate metabolic process (GO:0046487) | 3.77358578 |
19 | protoporphyrinogen IX metabolic process (GO:0046501) | 3.76940556 |
20 | creatine metabolic process (GO:0006600) | 3.75388782 |
21 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 3.72134848 |
22 | 2-oxoglutarate metabolic process (GO:0006103) | 3.67499729 |
23 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.65122141 |
24 | negative regulation of cell killing (GO:0031342) | 3.65122141 |
25 | NADH metabolic process (GO:0006734) | 3.63237839 |
26 | aromatic amino acid family catabolic process (GO:0009074) | 3.61561710 |
27 | serine family amino acid metabolic process (GO:0009069) | 3.55955273 |
28 | kynurenine metabolic process (GO:0070189) | 3.55652719 |
29 | homocysteine metabolic process (GO:0050667) | 3.54586889 |
30 | tetrapyrrole biosynthetic process (GO:0033014) | 3.53718937 |
31 | aspartate family amino acid catabolic process (GO:0009068) | 3.46519736 |
32 | NIK/NF-kappaB signaling (GO:0038061) | 3.43308284 |
33 | fatty acid beta-oxidation (GO:0006635) | 3.42217842 |
34 | folic acid metabolic process (GO:0046655) | 3.40750780 |
35 | viral transcription (GO:0019083) | 3.39634161 |
36 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.38296090 |
37 | protoporphyrinogen IX biosynthetic process (GO:0006782) | 3.36674115 |
38 | carnitine metabolic process (GO:0009437) | 3.35868252 |
39 | heme metabolic process (GO:0042168) | 3.34569434 |
40 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.32046529 |
41 | valine metabolic process (GO:0006573) | 3.30534859 |
42 | tricarboxylic acid cycle (GO:0006099) | 3.29746467 |
43 | regulation of triglyceride catabolic process (GO:0010896) | 3.29411322 |
44 | regulation of cholesterol homeostasis (GO:2000188) | 3.28857987 |
45 | porphyrin-containing compound metabolic process (GO:0006778) | 3.28550412 |
46 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.26452495 |
47 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.26452495 |
48 | translational termination (GO:0006415) | 3.21489749 |
49 | apoptotic process involved in morphogenesis (GO:0060561) | 3.21037380 |
50 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.20977854 |
51 | indole-containing compound catabolic process (GO:0042436) | 3.19896537 |
52 | indolalkylamine catabolic process (GO:0046218) | 3.19896537 |
53 | tryptophan catabolic process (GO:0006569) | 3.19896537 |
54 | serine family amino acid biosynthetic process (GO:0009070) | 3.18691222 |
55 | negative regulation of necroptotic process (GO:0060546) | 3.17994930 |
56 | mucosal-associated lymphoid tissue development (GO:0048537) | 3.17356552 |
57 | Peyers patch development (GO:0048541) | 3.17356552 |
58 | negative regulation of cholesterol transport (GO:0032375) | 3.17347763 |
59 | negative regulation of sterol transport (GO:0032372) | 3.17347763 |
60 | fatty acid oxidation (GO:0019395) | 3.17051338 |
61 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.16667484 |
62 | oxidative phosphorylation (GO:0006119) | 3.15783612 |
63 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.14205587 |
64 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 3.12156607 |
65 | cellular ketone body metabolic process (GO:0046950) | 3.11072375 |
66 | cellular response to virus (GO:0098586) | 3.10568414 |
67 | regulation of necrotic cell death (GO:0010939) | 3.10304085 |
68 | modulation by virus of host process (GO:0019054) | 3.09346833 |
69 | alpha-amino acid catabolic process (GO:1901606) | 3.09196381 |
70 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 3.08994790 |
71 | lipid oxidation (GO:0034440) | 3.08297973 |
72 | proline biosynthetic process (GO:0006561) | 3.08215144 |
73 | carnitine shuttle (GO:0006853) | 3.07387458 |
74 | translational elongation (GO:0006414) | 3.06147017 |
75 | fatty acid catabolic process (GO:0009062) | 3.05221681 |
76 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.03608022 |
77 | urea cycle (GO:0000050) | 3.03547261 |
78 | urea metabolic process (GO:0019627) | 3.03547261 |
79 | response to peptidoglycan (GO:0032494) | 3.03107004 |
80 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 3.01983362 |
81 | intestinal cholesterol absorption (GO:0030299) | 3.00922910 |
82 | oxaloacetate metabolic process (GO:0006107) | 2.98132472 |
83 | tryptophan metabolic process (GO:0006568) | 2.97766623 |
84 | short-chain fatty acid metabolic process (GO:0046459) | 2.97617264 |
85 | tricarboxylic acid metabolic process (GO:0072350) | 2.97348088 |
86 | aromatic amino acid family metabolic process (GO:0009072) | 2.96421915 |
87 | fatty acid transmembrane transport (GO:1902001) | 2.96252924 |
88 | cellular amino acid catabolic process (GO:0009063) | 2.95350430 |
89 | modulation by symbiont of host cellular process (GO:0044068) | 2.95194352 |
90 | phospholipid efflux (GO:0033700) | 2.93579375 |
91 | positive thymic T cell selection (GO:0045059) | 2.93102394 |
92 | positive regulation of triglyceride metabolic process (GO:0090208) | 2.91856727 |
93 | activation of MAPKKK activity (GO:0000185) | 2.91372366 |
94 | acetyl-CoA metabolic process (GO:0006084) | 2.90404151 |
95 | regulation of necroptotic process (GO:0060544) | 2.90288262 |
96 | galactose catabolic process (GO:0019388) | 2.89630485 |
97 | detection of bacterium (GO:0016045) | 2.89604989 |
98 | negative regulation of fatty acid biosynthetic process (GO:0045717) | 2.87800859 |
99 | pentose-phosphate shunt (GO:0006098) | 2.87773238 |
100 | response to mercury ion (GO:0046689) | 2.86195991 |
101 | high-density lipoprotein particle remodeling (GO:0034375) | 2.85871116 |
102 | nucleoside diphosphate biosynthetic process (GO:0009133) | 2.85851233 |
103 | oxygen transport (GO:0015671) | 2.85340517 |
104 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.85139758 |
105 | nitrogen cycle metabolic process (GO:0071941) | 2.85042659 |
106 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.84950172 |
107 | fructose metabolic process (GO:0006000) | 2.83137934 |
108 | skeletal muscle contraction (GO:0003009) | 2.83108958 |
109 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 2.82235019 |
110 | 4-hydroxyproline metabolic process (GO:0019471) | 2.81891081 |
111 | drug catabolic process (GO:0042737) | 2.81700298 |
112 | regulation of fatty acid oxidation (GO:0046320) | 2.81385622 |
113 | ethanol oxidation (GO:0006069) | 2.81245149 |
114 | negative regulation of fibrinolysis (GO:0051918) | 2.80668876 |
115 | maternal placenta development (GO:0001893) | 2.80543227 |
116 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.80346531 |
117 | pyrimidine nucleoside catabolic process (GO:0046135) | 2.80261558 |
118 | nucleoside salvage (GO:0043174) | 2.79222790 |
119 | monocarboxylic acid catabolic process (GO:0072329) | 2.78664565 |
120 | DNA deamination (GO:0045006) | 2.78378922 |
121 | carboxylic acid catabolic process (GO:0046395) | 2.78278396 |
122 | organic acid catabolic process (GO:0016054) | 2.78278396 |
123 | regulation of cholesterol metabolic process (GO:0090181) | 2.78092577 |
124 | ATP synthesis coupled proton transport (GO:0015986) | 2.77899754 |
125 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 2.77899754 |
126 | leukocyte aggregation (GO:0070486) | 2.76662640 |
127 | nucleotide salvage (GO:0043173) | 2.76161754 |
128 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.76154376 |
129 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.76154376 |
130 | modulation by symbiont of host immune response (GO:0052553) | 2.76154376 |
131 | positive regulation by symbiont of host defense response (GO:0052509) | 2.76154376 |
132 | modulation by symbiont of host defense response (GO:0052031) | 2.76154376 |
133 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.76154376 |
134 | regulation of gamma-delta T cell activation (GO:0046643) | 2.74667962 |
135 | bile acid biosynthetic process (GO:0006699) | 2.74180827 |
136 | protein targeting to ER (GO:0045047) | 2.74092964 |
137 | pyrimidine-containing compound salvage (GO:0008655) | 2.73418533 |
138 | pyrimidine nucleoside salvage (GO:0043097) | 2.73418533 |
139 | plasma lipoprotein particle assembly (GO:0034377) | 2.73407270 |
140 | amino-acid betaine transport (GO:0015838) | 2.72850387 |
141 | carnitine transport (GO:0015879) | 2.72850387 |
142 | negative regulation of cell size (GO:0045792) | 2.72459608 |
143 | respiratory electron transport chain (GO:0022904) | 2.72300400 |
144 | erythrocyte maturation (GO:0043249) | 2.71500236 |
145 | ribosomal small subunit biogenesis (GO:0042274) | 2.69638564 |
146 | regulation of early endosome to late endosome transport (GO:2000641) | 2.69259627 |
147 | embryonic process involved in female pregnancy (GO:0060136) | 2.67794385 |
148 | detection of other organism (GO:0098543) | 2.67625312 |
149 | regulation of chromatin binding (GO:0035561) | 2.66493905 |
150 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 2.65396348 |
151 | intracellular estrogen receptor signaling pathway (GO:0030520) | 2.64832344 |
152 | thymic T cell selection (GO:0045061) | 2.63073995 |
153 | barbed-end actin filament capping (GO:0051016) | 2.62583459 |
154 | negative regulation of viral release from host cell (GO:1902187) | 2.59922210 |
155 | mannose metabolic process (GO:0006013) | 2.55800753 |
156 | regulation of mammary gland epithelial cell proliferation (GO:0033599) | 2.55777657 |
157 | positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling | 2.51028966 |
158 | germinal center formation (GO:0002467) | 2.48483511 |
159 | intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress (GO:0070059) | 2.47150967 |
160 | pentose metabolic process (GO:0019321) | 2.43174268 |
161 | granulocyte differentiation (GO:0030851) | 2.42610263 |
162 | gas transport (GO:0015669) | 2.41413159 |
163 | negative regulation of myotube differentiation (GO:0010832) | 2.41303118 |
164 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.40219587 |
165 | purine nucleotide salvage (GO:0032261) | 2.38250598 |
166 | response to muramyl dipeptide (GO:0032495) | 2.38231474 |
167 | endoplasmic reticulum calcium ion homeostasis (GO:0032469) | 2.36849279 |
168 | glucose catabolic process (GO:0006007) | 2.36846107 |
169 | mature B cell differentiation involved in immune response (GO:0002313) | 2.36584333 |
170 | negative regulation of necrotic cell death (GO:0060547) | 2.36366698 |
171 | regulation of superoxide anion generation (GO:0032928) | 2.36003594 |
172 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.35970222 |
173 | negative regulation of toll-like receptor signaling pathway (GO:0034122) | 2.34345595 |
174 | actin-myosin filament sliding (GO:0033275) | 2.32500205 |
175 | muscle filament sliding (GO:0030049) | 2.32500205 |
176 | regulation of mast cell degranulation (GO:0043304) | 2.32047253 |
177 | erythrocyte development (GO:0048821) | 2.31809387 |
178 | regulation of leukocyte degranulation (GO:0043300) | 2.30523610 |
179 | NADPH regeneration (GO:0006740) | 2.30101737 |
180 | regulation of NFAT protein import into nucleus (GO:0051532) | 2.30041291 |
181 | negative regulation of peptidyl-serine phosphorylation (GO:0033137) | 2.28250604 |
182 | pinocytosis (GO:0006907) | 2.28195940 |
183 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.28068516 |
184 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.28049127 |
185 | epithelial cell differentiation involved in prostate gland development (GO:0060742) | 2.27909489 |
186 | gluconeogenesis (GO:0006094) | 2.27734890 |
187 | cellular response to arsenic-containing substance (GO:0071243) | 2.25700511 |
Rank | Gene Set | Z-score |
---|---|---|
1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 4.74137274 |
2 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.79637824 |
3 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 3.48053982 |
4 | * EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 3.42193923 |
5 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 3.41212351 |
6 | * CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 2.50779506 |
7 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.33593903 |
8 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 2.23994265 |
9 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 2.11880910 |
10 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.09031505 |
11 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.06471871 |
12 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.03064758 |
13 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.01900545 |
14 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.99779574 |
15 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.98519531 |
16 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.95493200 |
17 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.87242531 |
18 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.81970689 |
19 | MYC_22102868_ChIP-Seq_BL_Human | 1.79862301 |
20 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.77160933 |
21 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.75772228 |
22 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.75373165 |
23 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.75156396 |
24 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.75005180 |
25 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.74441947 |
26 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.74062890 |
27 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.71635006 |
28 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.68045883 |
29 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.65475692 |
30 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.63175646 |
31 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.60277225 |
32 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.57535051 |
33 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.56848048 |
34 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.54933853 |
35 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.54600223 |
36 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.53886424 |
37 | * ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.53323105 |
38 | GATA1_22025678_ChIP-Seq_K562_Human | 1.50267969 |
39 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.45568749 |
40 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.45495170 |
41 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.45422675 |
42 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.43102599 |
43 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.40808866 |
44 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.39690387 |
45 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.38356854 |
46 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.37650867 |
47 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.36825561 |
48 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.34027272 |
49 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.32747430 |
50 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.31936842 |
51 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.31424520 |
52 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.31175117 |
53 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.29512813 |
54 | * CREB1_26743006_Chip-Seq_LNCaP_Human | 1.29282890 |
55 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.28266664 |
56 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.27829025 |
57 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.26130156 |
58 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.26072629 |
59 | KDM2B_26808549_Chip-Seq_K562_Human | 1.25869196 |
60 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.24899243 |
61 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.24810024 |
62 | ATF3_27146783_Chip-Seq_COLON_Human | 1.23834399 |
63 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.23279470 |
64 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.23043298 |
65 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.22899165 |
66 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.22702831 |
67 | * TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.22021784 |
68 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.21610159 |
69 | * CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.21375293 |
70 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.21104906 |
71 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.20789898 |
72 | * P68_20966046_ChIP-Seq_HELA_Human | 1.19835042 |
73 | GATA1_19941826_ChIP-Seq_K562_Human | 1.18881624 |
74 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.18862767 |
75 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.18807111 |
76 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.18674295 |
77 | * TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.18633609 |
78 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.18600731 |
79 | * PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.18527924 |
80 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.17786445 |
81 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.17762241 |
82 | CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.17680626 |
83 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.17583422 |
84 | MAF_26560356_Chip-Seq_TH2_Human | 1.17319523 |
85 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.16420350 |
86 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.16156955 |
87 | * NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.15852572 |
88 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.15388008 |
89 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.14984400 |
90 | * KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.14965225 |
91 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 1.13780695 |
92 | MAF_26560356_Chip-Seq_TH1_Human | 1.13192835 |
93 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.12564471 |
94 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.12239067 |
95 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.11919632 |
96 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.11680533 |
97 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.11481591 |
98 | E2F7_22180533_ChIP-Seq_HELA_Human | 1.11070782 |
99 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.10548483 |
100 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.10328028 |
101 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 1.09955124 |
102 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.09449483 |
103 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.08474016 |
104 | * KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.06972221 |
105 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.06909220 |
106 | SA1_27219007_Chip-Seq_Bcells_Human | 1.06601604 |
107 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.06535147 |
108 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.06363627 |
109 | * GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.06187623 |
110 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.06055428 |
111 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.05369276 |
112 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.04858055 |
113 | PHF8_20622854_ChIP-Seq_HELA_Human | 1.04693435 |
114 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.04480284 |
115 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.04337499 |
116 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.04134735 |
117 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.03868844 |
118 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.03516219 |
119 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.02943014 |
120 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.02505478 |
121 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.02377780 |
122 | * TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.02224863 |
123 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.01521992 |
124 | * CTCF_21964334_Chip-Seq_Bcells_Human | 1.01236451 |
125 | UTX_26944678_Chip-Seq_JUKART_Human | 1.01163231 |
126 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.01155338 |
127 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 1.01069843 |
128 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.00796961 |
129 | * NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.00513515 |
130 | GATA6_25053715_ChIP-Seq_YYC3_Human | 1.00496042 |
131 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.00225031 |
132 | * DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.00172014 |
133 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.99953773 |
134 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.99854664 |
135 | OCT4_18692474_ChIP-Seq_MEFs_Mouse | 0.98635103 |
136 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 0.98377585 |
137 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.96194849 |
138 | FOXP1_21924763_ChIP-Seq_HESCs_Human | 0.95833801 |
139 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 0.95352563 |
140 | * CTCF_21964334_ChIP-Seq_BJAB-B_Human | 0.94872027 |
141 | E2F1_20622854_ChIP-Seq_HELA_Human | 0.94706727 |
142 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.92635131 |
143 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 0.92601289 |
144 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 0.92576179 |
145 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 0.92348948 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0005360_urolithiasis | 4.84002618 |
2 | MP0002139_abnormal_hepatobiliary_system | 4.73342389 |
3 | MP0009840_abnormal_foam_cell | 3.78531403 |
4 | MP0005085_abnormal_gallbladder_physiolo | 3.71594841 |
5 | MP0003806_abnormal_nucleotide_metabolis | 3.54790276 |
6 | MP0005365_abnormal_bile_salt | 3.43095261 |
7 | MP0005083_abnormal_biliary_tract | 3.14560899 |
8 | MP0008875_abnormal_xenobiotic_pharmacok | 3.00018004 |
9 | MP0003303_peritoneal_inflammation | 2.80199888 |
10 | MP0009278_abnormal_bone_marrow | 2.54665686 |
11 | MP0002837_dystrophic_cardiac_calcinosis | 2.46265065 |
12 | MP0001666_abnormal_nutrient_absorption | 2.45788331 |
13 | MP0003656_abnormal_erythrocyte_physiolo | 2.45021384 |
14 | MP0003646_muscle_fatigue | 2.35463025 |
15 | MP0003191_abnormal_cellular_cholesterol | 2.32297586 |
16 | MP0005332_abnormal_amino_acid | 2.28044555 |
17 | MP0006036_abnormal_mitochondrial_physio | 2.25747841 |
18 | MP0010329_abnormal_lipoprotein_level | 2.14860166 |
19 | MP0008260_abnormal_autophagy | 2.07401594 |
20 | MP0005451_abnormal_body_composition | 2.07088428 |
21 | MP0003252_abnormal_bile_duct | 2.03992697 |
22 | MP0003195_calcinosis | 1.95291201 |
23 | MP0003172_abnormal_lysosome_physiology | 1.85788434 |
24 | MP0003453_abnormal_keratinocyte_physiol | 1.83764256 |
25 | MP0009643_abnormal_urine_homeostasis | 1.83267597 |
26 | MP0000609_abnormal_liver_physiology | 1.78114309 |
27 | MP0004019_abnormal_vitamin_homeostasis | 1.77448288 |
28 | MP0000678_abnormal_parathyroid_gland | 1.75097555 |
29 | MP0004510_myositis | 1.74946905 |
30 | MP0005319_abnormal_enzyme/_coenzyme | 1.73542939 |
31 | MP0005397_hematopoietic_system_phenotyp | 1.57039740 |
32 | MP0001545_abnormal_hematopoietic_system | 1.57039740 |
33 | MP0000749_muscle_degeneration | 1.56712950 |
34 | MP0002118_abnormal_lipid_homeostasis | 1.53952396 |
35 | MP0005636_abnormal_mineral_homeostasis | 1.53495644 |
36 | MP0004147_increased_porphyrin_level | 1.53169732 |
37 | MP0001764_abnormal_homeostasis | 1.52380614 |
38 | MP0004233_abnormal_muscle_weight | 1.51737764 |
39 | MP0005330_cardiomyopathy | 1.51202492 |
40 | MP0002138_abnormal_hepatobiliary_system | 1.50855802 |
41 | MP0005076_abnormal_cell_differentiation | 1.49383282 |
42 | MP0003693_abnormal_embryo_hatching | 1.48698839 |
43 | MP0005464_abnormal_platelet_physiology | 1.46481668 |
44 | MP0006035_abnormal_mitochondrial_morpho | 1.45225504 |
45 | MP0004084_abnormal_cardiac_muscle | 1.44252017 |
46 | MP0005000_abnormal_immune_tolerance | 1.43938835 |
47 | MP0005670_abnormal_white_adipose | 1.43036776 |
48 | MP0002398_abnormal_bone_marrow | 1.39372482 |
49 | MP0002396_abnormal_hematopoietic_system | 1.39320396 |
50 | MP0004858_abnormal_nervous_system | 1.37268524 |
51 | MP0002419_abnormal_innate_immunity | 1.35524258 |
52 | MP0002132_abnormal_respiratory_system | 1.34894307 |
53 | MP0005387_immune_system_phenotype | 1.34743010 |
54 | MP0001790_abnormal_immune_system | 1.34743010 |
55 | MP0004043_abnormal_pH_regulation | 1.33937510 |
56 | MP0001849_ear_inflammation | 1.31614795 |
57 | MP0001819_abnormal_immune_cell | 1.31614376 |
58 | MP0002420_abnormal_adaptive_immunity | 1.31134148 |
59 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.30733107 |
60 | MP0000759_abnormal_skeletal_muscle | 1.29600765 |
61 | MP0002269_muscular_atrophy | 1.26508975 |
62 | MP0010234_abnormal_vibrissa_follicle | 1.26048988 |
63 | MP0004130_abnormal_muscle_cell | 1.25978424 |
64 | MP0005666_abnormal_adipose_tissue | 1.25578732 |
65 | MP0004185_abnormal_adipocyte_glucose | 1.25432341 |
66 | MP0002723_abnormal_immune_serum | 1.24757656 |
67 | MP0004036_abnormal_muscle_relaxation | 1.24569315 |
68 | MP0004215_abnormal_myocardial_fiber | 1.24081398 |
69 | MP0003186_abnormal_redox_activity | 1.23497879 |
70 | MP0000703_abnormal_thymus_morphology | 1.22653697 |
71 | MP0000858_altered_metastatic_potential | 1.20298247 |
72 | MP0001800_abnormal_humoral_immune | 1.18867431 |
73 | MP0009379_abnormal_foot_pigmentation | 1.17398081 |
74 | MP0000747_muscle_weakness | 1.17124342 |
75 | MP0001835_abnormal_antigen_presentation | 1.16537636 |
76 | MP0002148_abnormal_hypersensitivity_rea | 1.15409910 |
77 | MP0002429_abnormal_blood_cell | 1.15298798 |
78 | MP0002452_abnormal_antigen_presenting | 1.15150180 |
79 | MP0000716_abnormal_immune_system | 1.14347419 |
80 | MP0001756_abnormal_urination | 1.14031240 |
81 | MP0003866_abnormal_defecation | 1.11963106 |
82 | MP0003705_abnormal_hypodermis_morpholog | 1.08534711 |
83 | MP0008961_abnormal_basal_metabolism | 1.07729343 |
84 | MP0002877_abnormal_melanocyte_morpholog | 1.07458478 |
85 | MP0000598_abnormal_liver_morphology | 1.07011121 |
86 | MP0000689_abnormal_spleen_morphology | 1.05160432 |
87 | MP0004145_abnormal_muscle_electrophysio | 1.05134436 |
88 | MP0000751_myopathy | 1.04876406 |
89 | MP0004808_abnormal_hematopoietic_stem | 1.04091971 |
90 | MP0004087_abnormal_muscle_fiber | 1.02637766 |
91 | MP0002106_abnormal_muscle_physiology | 1.01142403 |
92 | MP0002078_abnormal_glucose_homeostasis | 1.00573907 |
93 | MP0005266_abnormal_metabolism | 1.00016058 |
94 | MP0008469_abnormal_protein_level | 0.98523436 |
95 | MP0000750_abnormal_muscle_regeneration | 0.98004784 |
96 | MP0002405_respiratory_system_inflammati | 0.96971259 |
97 | MP0009931_abnormal_skin_appearance | 0.96059889 |
98 | MP0003724_increased_susceptibility_to | 0.95124319 |
99 | MP0005310_abnormal_salivary_gland | 0.94862054 |
100 | MP0002254_reproductive_system_inflammat | 0.94748513 |
101 | MP0003011_delayed_dark_adaptation | 0.93374636 |
102 | MP0001765_abnormal_ion_homeostasis | 0.93062517 |
103 | MP0001533_abnormal_skeleton_physiology | 0.91954555 |
104 | MP0003111_abnormal_nucleus_morphology | 0.91872115 |
105 | MP0001873_stomach_inflammation | 0.90481778 |
106 | MP0000313_abnormal_cell_death | 0.90432274 |
107 | MP0002796_impaired_skin_barrier | 0.90416836 |
108 | MP0000685_abnormal_immune_system | 0.89443973 |
109 | MP0003300_gastrointestinal_ulcer | 0.88954236 |
110 | MP0000015_abnormal_ear_pigmentation | 0.88295452 |
111 | MP0003221_abnormal_cardiomyocyte_apopto | 0.88174090 |
112 | MP0010155_abnormal_intestine_physiology | 0.87306977 |
113 | MP0004957_abnormal_blastocyst_morpholog | 0.86891663 |
114 | MP0000490_abnormal_crypts_of | 0.86778330 |
115 | MP0005166_decreased_susceptibility_to | 0.85741799 |
116 | MP0009333_abnormal_splenocyte_physiolog | 0.85605978 |
117 | MP0000003_abnormal_adipose_tissue | 0.85382698 |
118 | MP0004381_abnormal_hair_follicle | 0.85375327 |
119 | MP0009642_abnormal_blood_homeostasis | 0.84953208 |
120 | MP0003878_abnormal_ear_physiology | 0.84778660 |
121 | MP0005377_hearing/vestibular/ear_phenot | 0.84778660 |
122 | MP0000733_abnormal_muscle_development | 0.84659093 |
123 | MP0005671_abnormal_response_to | 0.83708157 |
124 | MP0003763_abnormal_thymus_physiology | 0.83028766 |
125 | MP0005058_abnormal_lysosome_morphology | 0.82440403 |
126 | MP0002971_abnormal_brown_adipose | 0.81839615 |
127 | MP0002136_abnormal_kidney_physiology | 0.80794032 |
128 | MP0005375_adipose_tissue_phenotype | 0.80136084 |
129 | MP0003436_decreased_susceptibility_to | 0.77383696 |
130 | MP0003868_abnormal_feces_composition | 0.77027872 |
131 | MP0010630_abnormal_cardiac_muscle | 0.76490102 |
132 | MP0004947_skin_inflammation | 0.75967926 |
133 | MP0004264_abnormal_extraembryonic_tissu | 0.75374264 |
134 | MP0000358_abnormal_cell_content/ | 0.75361849 |
135 | MP0005501_abnormal_skin_physiology | 0.74344002 |
136 | MP0002822_catalepsy | 0.74105959 |
137 | MP0008775_abnormal_heart_ventricle | 0.73114925 |
138 | MP0001544_abnormal_cardiovascular_syste | 0.72845742 |
139 | MP0005385_cardiovascular_system_phenoty | 0.72845742 |
140 | MP0009763_increased_sensitivity_to | 0.71834520 |
141 | MP0001663_abnormal_digestive_system | 0.71470903 |
142 | MP0005025_abnormal_response_to | 0.69624486 |
143 | MP0005376_homeostasis/metabolism_phenot | 0.68518594 |
144 | MP0003137_abnormal_impulse_conducting | 0.68076790 |
145 | MP0002332_abnormal_exercise_endurance | 0.67142177 |
146 | MP0000477_abnormal_intestine_morphology | 0.66200016 |
147 | MP0001845_abnormal_inflammatory_respons | 0.64590895 |
148 | MP0009785_altered_susceptibility_to | 0.63938266 |
149 | MP0002722_abnormal_immune_system | 0.63299463 |
150 | MP0005334_abnormal_fat_pad | 0.62193629 |
151 | MP0002972_abnormal_cardiac_muscle | 0.61975179 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 4.22956041 |
2 | Hypoglycemic coma (HP:0001325) | 3.95569494 |
3 | Xanthomatosis (HP:0000991) | 3.83182840 |
4 | Muscle fiber inclusion bodies (HP:0100299) | 3.81466243 |
5 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 3.69266753 |
6 | Myoglobinuria (HP:0002913) | 3.66289523 |
7 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 3.65385804 |
8 | Nemaline bodies (HP:0003798) | 3.63312749 |
9 | Hyperammonemia (HP:0001987) | 3.63026629 |
10 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 3.62826623 |
11 | Hyperglycinuria (HP:0003108) | 3.62056878 |
12 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.55077791 |
13 | Eczematoid dermatitis (HP:0000976) | 3.54505361 |
14 | Ketosis (HP:0001946) | 3.48179202 |
15 | Gout (HP:0001997) | 3.45971349 |
16 | Dicarboxylic aciduria (HP:0003215) | 3.43826606 |
17 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 3.43826606 |
18 | Rhabdomyolysis (HP:0003201) | 3.35467451 |
19 | Hyperglycinemia (HP:0002154) | 3.33386292 |
20 | Intrahepatic cholestasis (HP:0001406) | 3.32423601 |
21 | Hepatic necrosis (HP:0002605) | 3.24123362 |
22 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.19434208 |
23 | Abnormality of glycine metabolism (HP:0010895) | 3.19434208 |
24 | Hyperlipoproteinemia (HP:0010980) | 3.11781439 |
25 | Late onset (HP:0003584) | 3.07718373 |
26 | Distal lower limb muscle weakness (HP:0009053) | 3.04862494 |
27 | Malnutrition (HP:0004395) | 3.00882493 |
28 | Deep venous thrombosis (HP:0002625) | 2.99678782 |
29 | Ketoacidosis (HP:0001993) | 2.97372276 |
30 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.91590099 |
31 | Hypobetalipoproteinemia (HP:0003563) | 2.90744105 |
32 | Generalized aminoaciduria (HP:0002909) | 2.86026280 |
33 | Increased connective tissue (HP:0009025) | 2.82338831 |
34 | Hypoalphalipoproteinemia (HP:0003233) | 2.82302684 |
35 | Increased IgE level (HP:0003212) | 2.79624377 |
36 | Poikilocytosis (HP:0004447) | 2.79199125 |
37 | Hyperbilirubinemia (HP:0002904) | 2.78438266 |
38 | Increased muscle lipid content (HP:0009058) | 2.77541331 |
39 | Ileus (HP:0002595) | 2.75698633 |
40 | Hypolipoproteinemia (HP:0010981) | 2.75095469 |
41 | Ventricular tachycardia (HP:0004756) | 2.72425748 |
42 | Lethargy (HP:0001254) | 2.70263220 |
43 | Bulbar palsy (HP:0001283) | 2.69907358 |
44 | Nausea (HP:0002018) | 2.66929598 |
45 | Metabolic acidosis (HP:0001942) | 2.66794056 |
46 | Type 1 muscle fiber predominance (HP:0003803) | 2.66504380 |
47 | Sudden death (HP:0001699) | 2.65865528 |
48 | Right ventricular cardiomyopathy (HP:0011663) | 2.60769346 |
49 | Cerebral edema (HP:0002181) | 2.60432465 |
50 | Hepatocellular necrosis (HP:0001404) | 2.60416098 |
51 | Reticulocytosis (HP:0001923) | 2.60277206 |
52 | Exercise-induced myalgia (HP:0003738) | 2.59032576 |
53 | Petechiae (HP:0000967) | 2.57859595 |
54 | Hypertensive crisis (HP:0100735) | 2.55626914 |
55 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.54813815 |
56 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.54813815 |
57 | Cholelithiasis (HP:0001081) | 2.52251958 |
58 | Ragged-red muscle fibers (HP:0003200) | 2.51915403 |
59 | Progressive muscle weakness (HP:0003323) | 2.49124673 |
60 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.47876402 |
61 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.47297389 |
62 | EMG: myopathic abnormalities (HP:0003458) | 2.46709899 |
63 | Abnormal gallbladder physiology (HP:0012438) | 2.44367302 |
64 | Cholecystitis (HP:0001082) | 2.44367302 |
65 | Abnormality of purine metabolism (HP:0004352) | 2.43503120 |
66 | Distal lower limb amyotrophy (HP:0008944) | 2.43012134 |
67 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.41899091 |
68 | Palpitations (HP:0001962) | 2.40037348 |
69 | Ventricular fibrillation (HP:0001663) | 2.38803499 |
70 | Increased intramyocellular lipid droplets (HP:0012240) | 2.36804332 |
71 | Diaphragmatic weakness (HP:0009113) | 2.36297213 |
72 | Abnormality of cells of the erythroid lineage (HP:0012130) | 2.34547791 |
73 | Muscle hypertrophy of the lower extremities (HP:0008968) | 2.34115619 |
74 | Colitis (HP:0002583) | 2.34097058 |
75 | Multiple enchondromatosis (HP:0005701) | 2.33647064 |
76 | Abnormal gallbladder morphology (HP:0012437) | 2.33118355 |
77 | Abnormality of nucleobase metabolism (HP:0010932) | 2.32525619 |
78 | Polycythemia (HP:0001901) | 2.32376333 |
79 | Vomiting (HP:0002013) | 2.32252606 |
80 | Muscle fiber splitting (HP:0003555) | 2.31943086 |
81 | Ulnar deviation of the wrist (HP:0003049) | 2.31716740 |
82 | Exercise-induced muscle cramps (HP:0003710) | 2.31397356 |
83 | Abnormality of macrophages (HP:0004311) | 2.31186173 |
84 | Abnormality of serum amino acid levels (HP:0003112) | 2.30970227 |
85 | Hyperuricemia (HP:0002149) | 2.29738018 |
86 | Increased purine levels (HP:0004368) | 2.29738018 |
87 | Recurrent abscess formation (HP:0002722) | 2.29143181 |
88 | Lactic acidosis (HP:0003128) | 2.28735545 |
89 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.28464571 |
90 | Gastrointestinal inflammation (HP:0004386) | 2.27599857 |
91 | Cellulitis (HP:0100658) | 2.27486157 |
92 | Difficulty climbing stairs (HP:0003551) | 2.27023983 |
93 | Prolonged partial thromboplastin time (HP:0003645) | 2.26934345 |
94 | Abnormality of urine glucose concentration (HP:0011016) | 2.26451156 |
95 | Glycosuria (HP:0003076) | 2.26451156 |
96 | Obstructive lung disease (HP:0006536) | 2.25235574 |
97 | Chronic obstructive pulmonary disease (HP:0006510) | 2.25235574 |
98 | Proximal tubulopathy (HP:0000114) | 2.24202744 |
99 | Abnormality of the thoracic spine (HP:0100711) | 2.24075064 |
100 | Acute encephalopathy (HP:0006846) | 2.23094278 |
101 | Abnormal number of erythroid precursors (HP:0012131) | 2.21761574 |
102 | Increased serum ferritin (HP:0003281) | 2.21723621 |
103 | Recurrent bacterial skin infections (HP:0005406) | 2.21448445 |
104 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.21367922 |
105 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.20965214 |
106 | Easy fatigability (HP:0003388) | 2.20771590 |
107 | Abnormality of reticulocytes (HP:0004312) | 2.17555073 |
108 | Acanthocytosis (HP:0001927) | 2.16877129 |
109 | Lipid accumulation in hepatocytes (HP:0006561) | 2.16238438 |
110 | Increased variability in muscle fiber diameter (HP:0003557) | 2.15007573 |
111 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 2.14703022 |
112 | Increased serum lactate (HP:0002151) | 2.14049116 |
113 | Abnormality of the Achilles tendon (HP:0005109) | 2.10640853 |
114 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.10570616 |
115 | Myopathic facies (HP:0002058) | 2.09351322 |
116 | Abnormality of transition element cation homeostasis (HP:0011030) | 2.08708754 |
117 | Calf muscle hypertrophy (HP:0008981) | 2.08232422 |
118 | Hyporeflexia of lower limbs (HP:0002600) | 2.07228726 |
119 | Abnormality of iron homeostasis (HP:0011031) | 2.06373911 |
120 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.05087049 |
121 | Testicular atrophy (HP:0000029) | 2.04823405 |
122 | Recurrent viral infections (HP:0004429) | 2.04029178 |
123 | Obstructive sleep apnea (HP:0002870) | 2.03454242 |
124 | Recurrent fungal infections (HP:0002841) | 2.03219774 |
125 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.01830436 |
126 | Inflammation of the large intestine (HP:0002037) | 2.00937792 |
127 | Stomatitis (HP:0010280) | 2.00263222 |
128 | Increased CSF lactate (HP:0002490) | 1.99586057 |
129 | Mitochondrial inheritance (HP:0001427) | 1.98953936 |
130 | Thin bony cortex (HP:0002753) | 1.98031931 |
131 | Stridor (HP:0010307) | 1.97585821 |
132 | Progressive external ophthalmoplegia (HP:0000590) | 1.95950223 |
133 | Hyperactive renin-angiotensin system (HP:0000841) | 1.93404372 |
134 | EMG: neuropathic changes (HP:0003445) | 1.92748827 |
135 | Increased cerebral lipofuscin (HP:0011813) | 1.92463830 |
136 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.92141291 |
137 | Paralysis (HP:0003470) | 1.91549094 |
138 | Truncus arteriosus (HP:0001660) | 1.91337778 |
139 | Asymmetric septal hypertrophy (HP:0001670) | 1.90767281 |
140 | Macrocytic anemia (HP:0001972) | 1.90674312 |
141 | Hyperparathyroidism (HP:0000843) | 1.90080701 |
142 | Brushfield spots (HP:0001088) | 1.89867485 |
143 | Abnormality of the intrinsic pathway (HP:0010989) | 1.89637441 |
144 | Muscle stiffness (HP:0003552) | 1.89329519 |
145 | Thoracic kyphosis (HP:0002942) | 1.89094094 |
146 | Acute necrotizing encephalopathy (HP:0006965) | 1.89035120 |
147 | Pustule (HP:0200039) | 1.88983136 |
148 | Syncope (HP:0001279) | 1.88644040 |
149 | Hemorrhage of the eye (HP:0011885) | 1.87261244 |
150 | Abnormality of the fingertips (HP:0001211) | 1.87185619 |
151 | CNS demyelination (HP:0007305) | 1.86801246 |
152 | Achilles tendon contracture (HP:0001771) | 1.85570972 |
153 | Neck muscle weakness (HP:0000467) | 1.84728305 |
154 | Seborrheic dermatitis (HP:0001051) | 1.84452622 |
155 | Hypochromic anemia (HP:0001931) | 1.83993483 |
156 | Fatigue (HP:0012378) | 1.82863259 |
157 | Gastrointestinal dysmotility (HP:0002579) | 1.79660245 |
158 | Abnormality of the gallbladder (HP:0005264) | 1.79255289 |
159 | External ophthalmoplegia (HP:0000544) | 1.79117907 |
160 | Prolonged bleeding time (HP:0003010) | 1.78695310 |
161 | Bowel incontinence (HP:0002607) | 1.78685352 |
162 | Gastrointestinal infarctions (HP:0005244) | 1.78236289 |
163 | Subaortic stenosis (HP:0001682) | 1.78115945 |
164 | Abnormality of the left ventricular outflow tract (HP:0011103) | 1.78115945 |
165 | Round ear (HP:0100830) | 1.77133325 |
166 | Axonal loss (HP:0003447) | 1.76119634 |
167 | Abnormal large intestine physiology (HP:0012700) | 1.76076987 |
168 | Hyperacusis (HP:0010780) | 1.75557222 |
169 | Difficulty running (HP:0009046) | 1.73045753 |
170 | Ulnar bowing (HP:0003031) | 1.72295540 |
171 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.71624242 |
172 | Generalized muscle weakness (HP:0003324) | 1.70725513 |
Rank | Gene Set | Z-score |
---|---|---|
1 | TRIB3 | 4.35351771 |
2 | BCKDK | 4.06714290 |
3 | PRPF4B | 3.61165627 |
4 | PKN2 | 3.37859212 |
5 | SMG1 | 2.96539473 |
6 | NME2 | 2.94823481 |
7 | ERN1 | 2.92925645 |
8 | TLK1 | 2.91593263 |
9 | MST1R | 2.81490566 |
10 | MAP3K10 | 2.26292410 |
11 | MAP3K11 | 2.17103683 |
12 | MAP4K1 | 1.94524064 |
13 | MAP2K2 | 1.83266335 |
14 | TESK2 | 1.78071486 |
15 | GRK6 | 1.75307902 |
16 | NME1 | 1.74804686 |
17 | FGFR4 | 1.66572829 |
18 | TTN | 1.60576381 |
19 | TYK2 | 1.59768713 |
20 | LMTK2 | 1.59113345 |
21 | EIF2AK1 | 1.56668959 |
22 | EPHA2 | 1.55728970 |
23 | NEK1 | 1.53765430 |
24 | KDR | 1.53690374 |
25 | FLT3 | 1.52299178 |
26 | MAP2K3 | 1.52095202 |
27 | RIPK4 | 1.51389518 |
28 | IRAK4 | 1.47329152 |
29 | NEK2 | 1.44708463 |
30 | PDK3 | 1.42469758 |
31 | PDK4 | 1.42469758 |
32 | PRKD2 | 1.32075700 |
33 | MAPK11 | 1.30622783 |
34 | PIK3CA | 1.26528282 |
35 | CDK12 | 1.26487592 |
36 | BUB1 | 1.23421935 |
37 | STK16 | 1.14298844 |
38 | TBK1 | 1.14014510 |
39 | ARAF | 1.12418944 |
40 | SIK3 | 1.10806225 |
41 | IRAK2 | 1.09906179 |
42 | HIPK2 | 1.09061623 |
43 | PTK6 | 1.09029025 |
44 | MAPKAPK3 | 1.07216908 |
45 | SCYL2 | 1.06644789 |
46 | STK10 | 1.05375705 |
47 | CDK19 | 1.05356030 |
48 | ZAP70 | 1.05181159 |
49 | OBSCN | 1.03768738 |
50 | TNK2 | 1.02977518 |
51 | CDK4 | 1.02286917 |
52 | TTK | 1.01496004 |
53 | EEF2K | 1.00018467 |
54 | RPS6KL1 | 0.99272508 |
55 | RPS6KC1 | 0.99272508 |
56 | MAP3K13 | 0.98266385 |
57 | MAPK12 | 0.98170322 |
58 | MAP3K14 | 0.95345661 |
59 | LRRK2 | 0.95087607 |
60 | RPS6KB2 | 0.94571487 |
61 | TAOK1 | 0.93072252 |
62 | STK4 | 0.92638448 |
63 | MAP2K6 | 0.89874614 |
64 | MARK2 | 0.89758891 |
65 | MAP3K3 | 0.89146752 |
66 | MAP3K8 | 0.88382081 |
67 | DAPK3 | 0.88236089 |
68 | IRAK3 | 0.87629081 |
69 | BMX | 0.85606979 |
70 | PIM2 | 0.84020243 |
71 | PHKG1 | 0.83394313 |
72 | PHKG2 | 0.83394313 |
73 | MAP3K7 | 0.83210449 |
74 | SIK1 | 0.83019490 |
75 | WNK4 | 0.82336404 |
76 | RPS6KA2 | 0.79743219 |
77 | TESK1 | 0.78317667 |
78 | RPS6KA6 | 0.77085537 |
79 | PRKG2 | 0.76462450 |
80 | MYLK | 0.76110317 |
81 | MAP3K1 | 0.75930976 |
82 | IKBKB | 0.74233297 |
83 | PIK3CG | 0.73285715 |
84 | VRK2 | 0.70148003 |
85 | MET | 0.69469926 |
86 | JAK2 | 0.66820026 |
87 | BTK | 0.65878510 |
88 | EIF2AK3 | 0.65779135 |
89 | IKBKE | 0.65099524 |
90 | WEE1 | 0.63991754 |
91 | BLK | 0.63126251 |
92 | KSR2 | 0.61607600 |
93 | AURKA | 0.60746653 |
94 | JAK3 | 0.60280612 |
95 | STK38 | 0.60160912 |
96 | TAOK3 | 0.58413359 |
97 | ILK | 0.57978653 |
98 | PAK4 | 0.56625012 |
99 | ABL2 | 0.56276473 |
100 | SIK2 | 0.55715047 |
101 | CDC42BPA | 0.55168752 |
102 | DYRK1B | 0.54453763 |
103 | HCK | 0.54400196 |
104 | AURKB | 0.54391499 |
105 | PRKAA1 | 0.54349104 |
106 | PRKCI | 0.52354879 |
107 | CDK7 | 0.51036153 |
108 | RPS6KA4 | 0.50251732 |
109 | MAP2K1 | 0.49056344 |
110 | JAK1 | 0.48660041 |
111 | DYRK3 | 0.48404414 |
112 | MAP3K5 | 0.48160298 |
113 | STK24 | 0.47383911 |
114 | NEK9 | 0.46753344 |
115 | CSK | 0.44903140 |
116 | MAPK7 | 0.44599725 |
117 | RPS6KA1 | 0.44585890 |
118 | AKT2 | 0.44057278 |
119 | STK38L | 0.43890579 |
120 | EPHB1 | 0.43883474 |
121 | MAPK15 | 0.43792128 |
122 | MAP3K6 | 0.43425699 |
123 | MARK3 | 0.43004167 |
124 | PTK2 | 0.41763591 |
125 | PRKD3 | 0.40843182 |
126 | MUSK | 0.40510383 |
127 | PLK1 | 0.40180587 |
128 | BRAF | 0.39181334 |
129 | PDK2 | 0.39066287 |
130 | MATK | 0.38888526 |
131 | PIM1 | 0.38285211 |
132 | TXK | 0.38206097 |
133 | PDPK1 | 0.38106439 |
134 | PRKAA2 | 0.36391744 |
135 | TAOK2 | 0.36017288 |
136 | RIPK1 | 0.34686132 |
137 | MTOR | 0.34435961 |
138 | ICK | 0.34158056 |
139 | MAPKAPK2 | 0.33730432 |
140 | PDK1 | 0.33452380 |
141 | SYK | 0.32352410 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.94175675 |
2 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.86927293 |
3 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 2.81449515 |
4 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.75526647 |
5 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.72687462 |
6 | Sulfur relay system_Homo sapiens_hsa04122 | 2.71861298 |
7 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 2.48181625 |
8 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.37378212 |
9 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.23695965 |
10 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.23114876 |
11 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.22023539 |
12 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.20896515 |
13 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.20669454 |
14 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.14897248 |
15 | Folate biosynthesis_Homo sapiens_hsa00790 | 2.10608309 |
16 | Carbon metabolism_Homo sapiens_hsa01200 | 2.10373463 |
17 | Ribosome_Homo sapiens_hsa03010 | 1.98041584 |
18 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.87672588 |
19 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.87417260 |
20 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.85784489 |
21 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.81550297 |
22 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.80251137 |
23 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.71581319 |
24 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.68776153 |
25 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.67734778 |
26 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.65554362 |
27 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.63428728 |
28 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.63223844 |
29 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.60664665 |
30 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.59520939 |
31 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.57058684 |
32 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.56977809 |
33 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.55873719 |
34 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.55290396 |
35 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.54676748 |
36 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.54542956 |
37 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.49975074 |
38 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.49068452 |
39 | Peroxisome_Homo sapiens_hsa04146 | 1.46593824 |
40 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.46037835 |
41 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.45820508 |
42 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.44261238 |
43 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.43163271 |
44 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.42109323 |
45 | Parkinsons disease_Homo sapiens_hsa05012 | 1.41906158 |
46 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.41656879 |
47 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.38709484 |
48 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.38324245 |
49 | Leishmaniasis_Homo sapiens_hsa05140 | 1.32134217 |
50 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.31441717 |
51 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.28299406 |
52 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.27627909 |
53 | Hepatitis C_Homo sapiens_hsa05160 | 1.26491435 |
54 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.26240242 |
55 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.24304478 |
56 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.22758952 |
57 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.21425556 |
58 | Apoptosis_Homo sapiens_hsa04210 | 1.20499022 |
59 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.20372842 |
60 | Bile secretion_Homo sapiens_hsa04976 | 1.17466692 |
61 | Galactose metabolism_Homo sapiens_hsa00052 | 1.16958325 |
62 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 1.14315385 |
63 | Hepatitis B_Homo sapiens_hsa05161 | 1.13804359 |
64 | Histidine metabolism_Homo sapiens_hsa00340 | 1.13742683 |
65 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.13593796 |
66 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.12225769 |
67 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.12188555 |
68 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.12054859 |
69 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.11825458 |
70 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.11219131 |
71 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.07784368 |
72 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.07500522 |
73 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.06491507 |
74 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.04529628 |
75 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.03905869 |
76 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.02557828 |
77 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.00382011 |
78 | ABC transporters_Homo sapiens_hsa02010 | 0.98957905 |
79 | Tuberculosis_Homo sapiens_hsa05152 | 0.98221102 |
80 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.97648823 |
81 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.96029262 |
82 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.95855552 |
83 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.94630899 |
84 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.92710845 |
85 | Influenza A_Homo sapiens_hsa05164 | 0.91923782 |
86 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.90942490 |
87 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.88300122 |
88 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.87482938 |
89 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.87202424 |
90 | Thyroid cancer_Homo sapiens_hsa05216 | 0.86538054 |
91 | Alzheimers disease_Homo sapiens_hsa05010 | 0.85272573 |
92 | HTLV-I infection_Homo sapiens_hsa05166 | 0.85120687 |
93 | Endometrial cancer_Homo sapiens_hsa05213 | 0.84788908 |
94 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.84693109 |
95 | Huntingtons disease_Homo sapiens_hsa05016 | 0.84447184 |
96 | Salmonella infection_Homo sapiens_hsa05132 | 0.84396633 |
97 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.84268868 |
98 | Shigellosis_Homo sapiens_hsa05131 | 0.82770283 |
99 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.81160484 |
100 | Retinol metabolism_Homo sapiens_hsa00830 | 0.80172870 |
101 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.79786120 |
102 | Prion diseases_Homo sapiens_hsa05020 | 0.79138281 |
103 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.79029037 |
104 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.77924882 |
105 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.77822047 |
106 | Measles_Homo sapiens_hsa05162 | 0.76026362 |
107 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.75630798 |
108 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.75265264 |
109 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.73902491 |
110 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.73467256 |
111 | Metabolic pathways_Homo sapiens_hsa01100 | 0.72604230 |
112 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.71765182 |
113 | Lysosome_Homo sapiens_hsa04142 | 0.70994168 |
114 | Legionellosis_Homo sapiens_hsa05134 | 0.70151899 |
115 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.69619838 |
116 | Proteasome_Homo sapiens_hsa03050 | 0.69363380 |
117 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.68324071 |
118 | Lysine degradation_Homo sapiens_hsa00310 | 0.68262530 |
119 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.67046595 |
120 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.64391323 |
121 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.64258638 |
122 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.64060274 |
123 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.61490568 |
124 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.61432738 |
125 | Malaria_Homo sapiens_hsa05144 | 0.61355070 |
126 | Endocytosis_Homo sapiens_hsa04144 | 0.59985966 |
127 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.58974295 |
128 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.58845746 |
129 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.58488525 |
130 | Viral myocarditis_Homo sapiens_hsa05416 | 0.57659400 |
131 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.57168634 |
132 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.57144218 |
133 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.56873524 |
134 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.56231336 |
135 | Insulin resistance_Homo sapiens_hsa04931 | 0.55810137 |
136 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.55678099 |
137 | Glioma_Homo sapiens_hsa05214 | 0.55208490 |
138 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.55099755 |
139 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.50840690 |
140 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.50638228 |
141 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.50459453 |
142 | Prostate cancer_Homo sapiens_hsa05215 | 0.49073905 |
143 | DNA replication_Homo sapiens_hsa03030 | 0.48112121 |
144 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.46379297 |
145 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.45036633 |
146 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.43420707 |
147 | Mineral absorption_Homo sapiens_hsa04978 | 0.43385913 |
148 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.39271945 |
149 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.39218879 |
150 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.37885126 |
151 | RNA polymerase_Homo sapiens_hsa03020 | 0.37589004 |
152 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.37518003 |
153 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.32696673 |
154 | Protein export_Homo sapiens_hsa03060 | 0.32172560 |
155 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.31151277 |
156 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.30544630 |
157 | Other glycan degradation_Homo sapiens_hsa00511 | 0.28147401 |
158 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.27191286 |
159 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.26915605 |
160 | Bladder cancer_Homo sapiens_hsa05219 | 0.25106995 |
161 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.24888219 |
162 | Base excision repair_Homo sapiens_hsa03410 | 0.24784840 |
163 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.23974074 |
164 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.23126846 |
165 | Mismatch repair_Homo sapiens_hsa03430 | 0.22934653 |
166 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.22893486 |